Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil
- PMID: 17912723
- DOI: 10.1002/mnfr.200700021
Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil
Abstract
In Mediterranean countries people would previously have consumed a diet with a high proportion of MUFA. Physical activity would have been intense with a low level of stress. The stearoyl-CoA desaturase (SCD1) system selected over thousands of years of this type of behavior must have adapted to a particular capacity of self regulation. Now, this pattern, called the "Mediterranean diet", has been broken and many people living by the Mediterranean consume a high quantity of calories, mainly from saturated or n-6-rich fats and the relative intake of MUFA has decreased. Simultaneously, physical activity has decreased and the pattern of stress has changed towards what is called a western lifestyle. In this new context, if people have a favorable, genetically conditioned SCD1 activity that will let them confront the new situation or else have some other compensatory mechanism, such as being keen on sport, etc, then they can prevent the appearance of some of the complications associated with the metabolic syndrome. If, on the other hand, the SCD1 pattern is genetically unfavorable for this new situation and they have a new cultural context, then they do not have the alternative compensatory mechanisms and the probability of developing the metabolic syndrome is high.
Similar articles
-
Polymorphisms in the SCD1 gene are associated with indices of stearoyl CoA desaturase activity and obesity: a prospective study.Mol Nutr Food Res. 2013 Dec;57(12):2177-84. doi: 10.1002/mnfr.201300208. Epub 2013 Aug 12. Mol Nutr Food Res. 2013. PMID: 23934750
-
Mediterranean diet and the Spanish paradox. A hypothesis.Med Hypotheses. 2013 Feb;80(2):150-5. doi: 10.1016/j.mehy.2012.11.015. Epub 2012 Dec 8. Med Hypotheses. 2013. PMID: 23228554
-
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008.Nutr Metab Cardiovasc Dis. 2010 May;20(4):284-94. doi: 10.1016/j.numecd.2009.12.007. Epub 2010 Mar 19. Nutr Metab Cardiovasc Dis. 2010. PMID: 20303720
-
Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome.Int J Obes (Lond). 2008 Jul;32(7):1076-82. doi: 10.1038/ijo.2008.55. Epub 2008 Apr 22. Int J Obes (Lond). 2008. PMID: 18427563 Review.
-
Mediterranean diet and metabolic diseases.Curr Opin Lipidol. 2008 Feb;19(1):63-8. doi: 10.1097/MOL.0b013e3282f2fa4d. Curr Opin Lipidol. 2008. PMID: 18196989 Review.
Cited by
-
The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects.Antioxidants (Basel). 2024 Mar 13;13(3):344. doi: 10.3390/antiox13030344. Antioxidants (Basel). 2024. PMID: 38539877 Free PMC article. Review.
-
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.Cells. 2024 Mar 4;13(5):450. doi: 10.3390/cells13050450. Cells. 2024. PMID: 38474414 Free PMC article. Review.
-
The effect of coconut oil and palm oil on anthropometric parameters: a clinical trial.BMC Nutr. 2024 Jan 10;10(1):9. doi: 10.1186/s40795-023-00812-y. BMC Nutr. 2024. PMID: 38200608 Free PMC article.
-
The Effects of Diets Enriched in Monounsaturated Oleic Acid on the Management and Prevention of Obesity: a Systematic Review of Human Intervention Studies.Adv Nutr. 2020 Jul 1;11(4):864-877. doi: 10.1093/advances/nmaa013. Adv Nutr. 2020. PMID: 32135008 Free PMC article.
-
Consumption of extra virgin olive oil improves body composition and blood pressure in women with excess body fat: a randomized, double-blinded, placebo-controlled clinical trial.Eur J Nutr. 2018 Oct;57(7):2445-2455. doi: 10.1007/s00394-017-1517-9. Epub 2017 Aug 14. Eur J Nutr. 2018. PMID: 28808791 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical